The Pyruvate Dehydrogenase Complex as a Target for Gene Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|3|3|239-245

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.3, Iss.3, 2003-06, pp. : 239-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy: How to Target the Kidney. Promises and Pitfalls

By  

Current Gene Therapy, Vol. 4, Iss. 1, 2004-03 ,pp. : 115-122

Bentham Science Publishers

Access to resources Recommend Favorite

CCR5 as Target for HIV-1 Gene Therapy

By  

Current Gene Therapy, Vol. 8, Iss. 4, 2008-08 ,pp. : 264-272

Bentham Science Publishers

Access to resources Recommend Favorite

The PIK3CA Gene as a Mutated Target for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. : 733-740

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 2, 2002-07 ,pp. : 151-165

Bentham Science Publishers

Access to resources Recommend Favorite

Cationic Lipid-DNA Complexes for Gene Therapy: Understanding the Relationship Between Complex Structure and Gene Delivery Pathways at the Molecular Level

By  

Current Medicinal Chemistry, Vol. 11, Iss. 2, 2004-01 ,pp. : 133-149

Bentham Science Publishers

Access to resources Recommend Favorite